B

Braeburn

Develops next-generation OUD medications with counseling

Regional Director - Southwest

Full-TimeUpdated on 10/23/2026
No salary listed
Expert
Bachelor's, Master's
New Mexico, USA+2 moreMore locations: California, USA | Arizona, USA
RemoteRemote within California, Arizona, or New Mexico; regional and national travel up to 50–60% as needed.
Sales & Account ManagementField Sales

About the job

Requirements
  • A bachelor's degree (BS/BA) is required; an advanced business degree is a plus.
  • At least 12 years of pharmaceutical experience, including at least 7 years of sales and/or field market access experience in biotech, specialty pharmaceutical, or device industries.
  • At least 5 years of first-line sales and/or field market access management experience.
  • Proven sales or field market access performance, evidenced by market performance reports and recognition awards in specialty pharmacy markets.
  • A demonstrated track record of building field-based teams and coaching and developing field-based professionals.
  • In-depth understanding of reimbursement and insurance coverage for physician-administered treatments.
  • Strong interpersonal, written, and oral communication skills.
  • Strong presentation, planning, and operational skills.
  • Ability to recruit, coach, and mentor.
  • Collaborative, team-oriented skills and operational values.
  • Strong work ethic and commitment to excellence.
  • Strong ethical behavior and commitment to compliance.
  • Willingness to travel regionally and nationally as needed, up to 50–60%.
  • Passion for improving healthcare for patients with substance use or mental health disorders.
  • Entrepreneurial attitude and/or experience in a start-up environment.
Responsibilities
  • Lead recruitment, coaching, development, and retention of top talent, and be accountable for the talent life cycle, including performance management, compensation reviews, and employee engagement.
  • Train, motivate, and coach Account Managers in all aspects of job performance within the assigned region using company-approved resources.
  • Execute field strategies and marketing plans to meet or exceed regional and national business objectives.
  • Participate in developing and implementing national sales strategy and related tactics.
  • Assist with developing and delivering field infrastructure and field training in support of the strategic business plan.
  • Develop and deliver business plans through periodic reviews with corporate leadership team members.
  • Develop a deep understanding of the assigned region, including care delivery, major payers, and public policy initiatives.
  • Identify and address region-specific opportunities and barriers to company success.
  • Review, analyze, and interpret field reports to ensure quarterly and annual objectives are met.
  • Foster compliant innovation in field approaches and practices, and ensure effective cross-functional leadership and collaboration with market access, medical affairs, government affairs, and other company partners.
  • Develop and implement effective regional communication.
  • Plan and execute regional sales.
  • Exercise sound judgment and ensure integrity and compliance with company policies in all activities and communications.
  • Manage regional-level expenses.
  • Work on and/or lead special project teams as identified.
Desired Qualifications
  • An advanced business degree is a plus.

About the company

Braeburn focuses on developing next-generation medications for opioid use disorder (OUD) and sells these therapies to healthcare providers, clinics, and patients with the aim of supporting recovery. The medicines are intended to be used together with counseling and support services as part of a comprehensive treatment plan for OUD. The company advances its goal through research, development, and commercialization of therapies, often in partnerships with other healthcare organizations, within the regulated pharmaceutical market. Unlike many generic care models, Braeburn emphasizes a mission-driven approach that combines medical treatments with patient support to help individuals reintegrate into their communities. The overall aim is to reduce the opioid crisis by providing effective, accessible treatments that help patients overcome addiction and rebuild their lives.

Company Size

201-500

Company Stage

Late Stage VC

Total Funding

$266M

Headquarters

Washington DC, District of Columbia

Founded

2012

Get referred to Braeburn

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Braeburn published 2026 CPDD and ASCP data showing withdrawal suppression and retention benefits.
  • Camurus said Brixadi captured roughly 32% of U.S. long-acting buprenorphine units in Q1 2026.
  • September 2026 JSAT safety analysis strengthens Braeburn's postmarketing evidence for prescribers and payers.

What critics are saying

  • Brixadi's intravenous misuse risk triggers REMS restrictions and serious-harm warnings across 2026 labeling.
  • Indivior's Sublocade remains the category leader, limiting Braeburn's pricing power through 2026.
  • Reported Camurus acquisition talks in September 2026 signal Braeburn's standalone future is uncertain.

What makes Braeburn unique

  • Brixadi offers weekly and monthly buprenorphine injections with room-temperature storage, unlike many rivals.
  • Braeburn expanded its U.S. commercial and medical affairs teams during 2026 for Brixadi adoption.
  • Camurus reported Braeburn drove 42% royalty growth in 2026 from U.S. Brixadi uptake.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

-4%

1 year growth

-1%

2 year growth

-1%
New York Globe
Sep 12th, 2025
Swedish Biotech Camurus in Talks to Buy US-Based Braeburn in $1 Billion Opioid Market Bet

Swedish biotech Camurus in talks to buy New York Globe-based Braeburn in $1 billion opioid market bet.

Braeburn
Sep 30th, 2024
Braeburn Debuts Inspiring Docuseries Celebrating Advocates Uplifting Communities to Combat the Opioid Crisis

(PLYMOUTH MEETING, PA - September 30, 2024) - Braeburn Inc. today announced the launch of Reframe and Reclaim: Shaping the Future of Recovery Stories, a mini docuseries on BraeburnRx.com aimed at destigmatizing opioid use disorder (OUD) and celebrating the compelling advocacy of community champions.

We-Ha.com LLC
Jul 6th, 2023
New Principal Named for West Hartford's Braeburn Elementary School

She will take over for Kim Ambroise, who had served as Braeburn’s interim principal since late 2022, following the departure of the former principal, Jeff Sousa, for a superintendent position in New Hartford.

Cision
May 23rd, 2023
Camurus Announces Fda Approval Of Brixadi™ For The Treatment Of Moderate To Severe Opioid Use Disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder. .

Braeburn
Sep 24th, 2021
Braeburn hires Joshua M. Cohen as Chief Medical Officer

Braeburn announces that Joshua M. Cohen, MD, MPH, FAHS has joined the company as Chief Medical Officer.